Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

SUMOylation in Glioblastoma: A Novel Therapeutic Target.

Fox BM, Janssen A, Estevez-Ordonez D, Gessler F, Vicario N, Chagoya G, Elsayed G, Sotoudeh H, Stetler W, Friedman GK, Bernstock JD.

Int J Mol Sci. 2019 Apr 15;20(8). pii: E1853. doi: 10.3390/ijms20081853. Review.

2.

Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.

Jang S, Janssen A, Aburjania Z, Robers MB, Harrison A, Dammalapati A, Cheng YQ, Chen H, Jaskula-Sztul R.

Oncotarget. 2017 Aug 7;8(41):70828-70840. doi: 10.18632/oncotarget.19993. eCollection 2017 Sep 19.

Supplemental Content

Loading ...
Support Center